ARTICLE SUMMARY:
Intrinsic Therapeutics won a rare PMA approval based on superiority data for its spine implant, Barricaid. How much impact does this kind of achievement have on a product’s commercial success?
Few spine devices require PMAs to get to market, and ultra-rarely are those approval decisions based on demonstration of clinical superiority.
